通过证书实现CO₂中和1
Vetter Pharma – 通过证书实现CO₂补偿 | 企业客户
拯救生命,同时保护气候:Vetter实现二氧化碳中和
Vetter是全球领先的制药行业服务提供商,专注于无菌生产和包装预充式注射器及其他注射系统,用于治疗多发性硬化症、严重类风湿性关节炎、癌症等疾病。该合同开发和制造组织(CDMO)支持全球药品制造商,从新药早期开发到全球分销。Vetter在德国拉文斯堡及其周边拥有三个生产基地,在奥地利和美国设有开发基地,并在新加坡、日本、韩国和中国设有销售办事处。这家家族所有的CDMO目前雇佣约5,700名员工,他们积极为公司可持续的未来做出贡献。Vetter在2021年实现了840百万欧元的年销售额。
二氧化碳排放——成功结合减排与抵消
Vetter是全球制药和生物技术公司的重要合作伙伴,支持它们生产关键药物。这种生产在洁净室中进行,需要恒定的温度、湿度和正压。然而,平衡供暖、制冷和压力消耗大量能源——并导致巨大的碳足迹。因此,Vetter决定对节能环保技术进行有针对性的投资,包括太阳能、地热和沼气装置,以及热电联产(CHP)机组。这些技术使Vetter自2014年以来减少了超过15,000吨的二氧化碳排放。
尽管所有减排措施都已用尽,但在能源密集且出于充分理由受到严格监管的制药行业,这些措施仍不足以实现零排放。然而,通过与核心银行德国商业银行的密切协商,Vetter通过用二氧化碳证书抵消剩余排放,仍然实现了气候中和。
根据公认标准CDM和Verra的二氧化碳证书
所使用的证书多数为CER(核证减排量)类型,并在联合国监管的清洁发展机制(CDM)下签发。同时,也使用了Verra核证碳标准下的项目和证书。这两项标准均确保补偿项目确实致力于实现永久性的二氧化碳减排,而这类减排在正常情况下是不会发生的。这一点由独立的第三方进行核查。
证书背后的项目通常还带来社会效益,例如创造新就业机会或改善能源供应。例如,CDM针对新兴国家,并支持它们的可持续发展。
Vetter的第一个补偿项目是哥斯达黎加的瓜纳卡斯特风电场,该公司自2020,起一直支持该项目。该风电场由55台风力涡轮机组成,有助于哥斯达黎加实现更气候友好的能源供应,同时创造就业机会。仅这一个项目就使Vetter抵消了超过15,000吨的二氧化碳排放。其他证书涉及墨西哥的一个风电场、尼泊尔的一个微型水电站和纳米比亚的太阳能发电厂。
成果
通过CO₂证书抵消CO₂排放,帮助Vetter在2020,年实现了其德国工厂的CO₂中和,并在2021年实现了所有国际工厂和办公室的CO₂中和。
您可能还感兴趣
企业金融在向可持续经济转型中扮演着关键角色。德国商业银行正在积极推动这一变革,并支持企业在其各自的...
德国商业银行的新白皮书探讨了金融机构(FIs)在促进和引导新兴市场可持续转型中的作用。
注:本页内容仅供企业、专业或机构客户使用,不面向消费者。关于所展示公司的可持续性相关陈述基于各公司提供的信息。
目标受众说明:本页内容仅供企业、专业或机构客户使用,不面向消费者。我们对可持续性的理解以及我们可持续战略的关键要素在我们的ESG框架中进行了描述,该框架特别披露了根本目标、标准、定义和方法基础。
完整英文原文
CO₂ neutrality through compensation with the help of certificates1
Saving lives, while protecting the climate: Vetter achieves CO₂ neutrality
Vetter is one of the world’s leading service providers for the pharmaceutical industry, specialising in the aseptic production and packaging of prefilled syringes and other injection systems for the treatment of multiple sclerosis, severe rheumatoid arthritis, cancer, and other illnesses. The contract development and manufacturing organisation (CDMO) supports drug manufacturers worldwide, from the early-stage development of new medicines to their global distribution. Vetter owns three production sites in and around Ravensburg/Germany, along with development sites in Austria and the US, together with sales offices in Singapore, Japan, South Korea and China. The family-owned CDMO currently employs around 5,700 staff, who actively contribute to the company’s sustainable future. Vetter generated annual sales of 840 million euros in 2021.
CO₂ emissions – successfully combining reduction and offset
Vetter is a strong partner for global pharmaceutical and biotech companies, supporting them with the production of vital medicines. This production takes place in clean rooms, which require constant temperatures, humidity and positive pressure. However, balancing heating, cooling and pressure consumes a lot of energy – and leads to a large carbon footprint. Vetter therefore decided to make targeted investments in energy-efficient and environmentally friendly technologies, including solar, geothermal and biogas installations next to a combined heat and power (CHP) unit. These technologies have allowed Vetter to reduce emissions by more than 15,000 tonnes of CO₂ since 2014.
Although all measures to reduce emissions have been exhausted, they have not been enough to reach zero emissions in the energy-intensive pharmaceutical industry, which is strongly regulated for good reason. Vetter nevertheless reached climate neutrality – in close consultation with its core bank Commerzbank – by offsetting the remaining emissions with CO₂ certificates.
CO₂ certificates under recognised standards CDM and Verra
The majority of the certificates used have been of the CER (Certified Emission Reductions) type and issued under the UN-regulated Clean Development Mechanism (CDM). Projects and certificates under the Verra Verified Carbon Standard have been used as well. Both standards ensure that compensation projects in fact work towards permanent CO₂ reduction that would otherwise not have been achieved. This is checked by independent third parties.
The projects behind the certificates usually also imply social benefits, for example, by creating new jobs or improving energy supply. The CDM, for example, targets emerging countries and supports them in their sustainable development.
Vetter’s first compensation project, which the company has supported since 2020, is Guanacaste Wind Farm in Costa Rica. The wind farm consists of 55 wind turbines and contributes to a more climate-friendly energy supply in Costa Rica, whilst creating jobs. This project alone allowed Vetter to offset more than 15,000 tonnes of CO₂ emissions. Other certificates pertain to a wind farm in Mexico, a micro-hydropower plant in Nepal and solar power plants in Namibia.
The result
Offsetting CO₂ emissions through CO₂ certificates helped Vetter to achieve CO₂ neutrality at its German sites in 2020, and at all international sites and offices in 2021.
You might also be interested in
Corporate finance has a key role to play in the transition towards a sustainable economy. Commerzbank is actively shaping this change, and is supporting companies in their individual...
Commerzbank’s new whitepaper explores the role of financial institutions (FIs) in facilitating and guiding the sustainable transition in emerging markets
Note: The content on this page is intended exclusively for corporate, professional or institutional clients and not for consumers. Sustainability-related statements regarding the companies presented are based on information provided by the respective company.
Note on the target audience: The content on this page is intended exclusively for corporate, professional or institutional clients and not for consumers. Our understanding of sustainability and the key elements of our sustainability strategy are described in our ESG framework, which in particular discloses the underlying objectives, criteria, definitions and methodological foundations.
预览 PDF
正在载入文档……
关键论点
- Vetter通过太阳能、地热、沼气和热电联产投资,自2014年以来减排超过15,000吨二氧化碳。
- 尽管受到监管限制,通过高质量二氧化碳证书(CER和Verra)抵消剩余排放仍实现了气候中和。
- 补偿项目还带来社会协同效益,如创造就业和改善能源供应。
- 德国商业银行作为核心银行,通过密切磋商促进了补偿战略的实施。
风险
- 制药行业的监管限制可能限制实现零排放。
- 二氧化碳证书的可用性和质量未来可能发生变化。
- 依赖补偿项目可能带来实施风险。